Source: International Congress 2018 – Pulmonary tuberculosis: long term complications, rehabilitation and challenges
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
G. Gupta (Mumbai, India), A. Chitnis (Mumbai, India). Assessment of lung functions in patients of pulmonary tuberculosis(PTB) after completion of their anti-tubercular medicationGaurav Gupta, A.S Chitnis. 2750

Member's Comments

No comment yet.

Related content which might interest you: “Antifibrotic therapy for fibrotic lung disease beyond idiopathic pulmonary fibrosis.” Bridget F. Collins and Ganesh Raghu. Eur Respir Rev 2019; 28: 190022. Source: Eur Respir Rev, 28 (154) 195022; 10.1183/16000617.5022-2019 Year: 2019 Assessment of chemotherapeutic results in cases with pulmonary tuberculosis confirmed bacteriologically and recorded in Bucharest, 1997-1999 Source: Eur Respir J 2001; 18: Suppl. 33, 323s Year: 2001 “Interferon-? liposome: a new system to improve drug delivery in the treatment of lung cancer”. Maysa Alhawamdeh, Mohammad Isreb, Abid Aziz, Badie K. Jacob, Diana Anderson and Mojgan Najafzadeh. ERJ Open Res 2021; 7: 00555-2020. Source: ERJ Open Res, 7 (4) 50555-2020; 10.1183/23120541.50555-2020 Year: 2021 Correlation between exercise capacity and different functional markers as an effectiveness of pulmonary rehabilitation in COPD. Kerti M, Balogh Zs, Kelemen K, Varga JNational Koranyi Institute for TB and Pulmonology, Department of Pulmonary Rehabilitation Source: International Congress 2017 – Latest insights into functional capacity, muscle weakness and physical activity in chronic lung diseases Year: 2017 “Recent lessons learned in the management of acute exacerbation of idiopathic pulmonary fibrosis.” Yasuhiro Kondoh, Vincent Cottin and Kevin K. Brown. Eur Respir Rev 2017; 26: 170050. Source: Eur Respir Rev, 27 (148) 175050; 10.1183/16000617.5050-2017 Year: 2018 “Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis.” Michael Kreuter, Marlies S. Wijsenbeek, Martina Vasakova, Paolo Spagnolo, Martin Kolb, Ulrich Costabel, Derek Weycker, Klaus-Uwe Kirchgaessler and Toby M. Maher. Eur Respir J 2016; 47: 1776–1784. Source: Eur Respir J 2016; 48: 593 Year: 2016 “A stepwise composite echocardiographic score predicts severe pulmonary hypertension in patients with interstitial lung disease” Simon Bax, Charlene Bredy, Aleksander Kempny, Konstantinos Dimopoulos, Anand Devaraj, Simon Walsh, Joseph Jacob, Arjun Nair, Maria Kokosi, Gregory Keir, Vasileios Kouranos, Peter M. George, Colm McCabe, Michael Wilde, Athol Wells, Wei Li, Stephen John Wort and Laura C. Price. ERJ Open Res 2018; 4: 00124-2017. Source: ERJ Open Res, 4 (3) 00124-2017-AUT; 10.1183/23120541.50124-2017 Year: 2018 The efficiency of the treatment of the patients with culture-positive pulmonary tuberculosis (CPPTB) in Gdannsk, Poland in 1995 and 2000 Source: Annual Congress 2005 - Epidemiology and control of tuberculosis and LTBI Year: 2005 “Pulmonary arterial hypertension in patients treated with interferon.” Laurent Savale, Caroline Sattler, Sven Günther, David Montani, Marie-Camille Chaumais, Swanny Perrin, Xavier Jaïs, Andrei Seferian, Roland Jovan, Sophie Bulifon, Florence Parent, Gérald Simonneau, Marc Humbert and Olivier Sitbon. Eur Respir J 2014; 44: 1627–1634. Source: Eur Respir J 2015; 46: 1854 Year: 2015 “Balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension.” Irene Lang, Bernhard C. Meyer, Takeshi Ogo, Hiromi Matsubara, Marcin Kurzyna, Hossein-Ardeschir Ghofrani, Eckhard Mayer and Philippe Brenot. Eur Respir Rev 2017; 26: 160119. Source: Eur Respir Rev, 26 (144) 165119; 10.1183/16000617.5119-2016 Year: 2017 “Long-term clinical and real-world experience with pirfenidone in the treatment of idiopathic pulmonary fibrosis.” Vincent Cottin and Toby Maher. Eur Respir Rev 2015; 24: 58–64. Source: Eur Respir Rev 2015; 24: 545 Year: 2015 “Cladribine improves lung cysts and pulmonary function in a child with histiocytosis.” Ralph Epaud, Hubert Ducou Le Pointe, Sylvie Fasola, Sandra Ploussard, Celine Delestrain, Chiara Sileo and Jean Donadieu. Eur Respir J 2015; 45: 831–833. Source: Eur Respir J 2016; 47: 692 Year: 2016 “Long-term outcomes of bronchial thermoplasty in subjects with severe asthma: a comparison of 3-year follow-up results from two prospective multicentre studies.” Geoffrey Chupp, Michel Laviolette, Lauren Cohn, Charlene McEvoy, Sandeep Bansal, Adrian Shifren, Sumita Khatri, G. Mark Grubb, Edmund McMullen, Racho Strauven and Joel N. Kline. Eur Respir J 2017; 50: 1700017. Source: Eur Respir J, 50 (4) 1750017; 10.1183/13993003.50017-2017 Year: 2017 Assessment of the results of the chemotherapy administrated to the patients with pulmonary tuberculosis in Bucharest (Romania) in 2000 Source: Eur Respir J 2002; 20: Suppl. 38, 547s Year: 2002 “Functional ageing in fibrotic interstitial lung disease: the impact of frailty on adverse health outcomes.” Sabina A. Guler, Joanne M. Kwan, Janice M. Leung, Nasreen Khalil, Pearce G. Wilcox and Christopher J. Ryerson. Eur Respir J 2020; 55: 1900647. Source: Eur Respir J, 55 (3) 1950647; 10.1183/13993003.50647-2019 Year: 2020 Bronchoscope-guided Catheter-directed therapy for Patients with Severe Asthma and Airway Stenosis. Shah W,Thong L,Redmond K,Murray J,Cormican LJ,Burke CM, Faul JL. Source: International Congress 2018 – Asthma and drugs Year: 2018 Response of the King’s brief interstitial lung disease (KBILD) questionnaire to pulmonary rehabilitation (PR) Source: International Congress 2015 – Latest insights in pulmonary rehabilitation and functional capacity Year: 2015 “Clinical phenotypes and outcomes of precapillary pulmonary hypertension of sickle cell disease.” Laurent Savale, Anoosha Habibi, François Lionnet, Bernard Maitre, Vincent Cottin, Xavier Jais, Ari Chaouat, Elise Artaud-Macari, Matthieu Canuet, Grégoire Prevot, Christelle Chantalat-Auger, David Montani, Olivier Sitbon, Fréderic Galacteros, Gérald Simonneau, Florence Parent, Pablo Bartolucci and Marc Humbert. Eur Respir J 2019; 54: 1900585. Source: Eur Respir J, 55 (1) 1950843; 10.1183/13993003.50585-2019 Year: 2020 The importance of pulmonary mineralogic analysis (PMA) in interstitial lung disease (ILD). A retrospective study of 226 samples from 2005 to 2011 Source: Annual Congress 2013 –Occupational respiratory diseases: asthma, silicosis and asbestosis Year: 2013 “2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS).” Nazzareno Galiè, Marc Humbert, Jean-Luc Vachiery, Simon Gibbs, Irene Lang, Adam Torbicki, Gérald Simonneau, Andrew Peacock, Anton Vonk Noordegraaf, Maurice Beghetti, Ardeschir Ghofrani, Miguel Angel Gomez Sanchez, Georg Hansmann, Walter Klepetko, Patrizio Lancellotti, Marco Matucci, Theresa McDonagh, Luc A. Pierard, Pedro T. Trindade, Maurizio Zompatori and Marius Hoeper. Eur Respir J 2015; 46: 903–975. Source: Eur Respir J 2015; 46: 1855-1856 Year: 2015